US Pharmacopeia Announces 2013-2014 Global Fellowships - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

US Pharmacopeia Announces 2013-2014 Global Fellowships



Recognized for establishing quality standards for medicines, food ingredients, and dietary supplements, the United States Pharmacopeial Convention (USP) announced the selection of its 2013-2014 USP Global Fellows. The Global Fellowship program has awarded $150,000 in research grants to support the work of early-career scientists with the goal of advancing research priorities in small moleculedrugs, biologics, excipients, dietary supplements, and food ingredients that address specific USP scientific or research needs.

Each year, USP conducts a competitive process for selecting fellows who are engaged in full-time study in a PhD or Pharm. D. program, medical school, or dental school, and whose works are directly relevant to USP’s priorities.

For the 2013-2014 academic year, three $50,000 USP Global Fellowship awards have been presented to the following students:

• Adam L. Kaylor, PhD candidate, Georgia Institute of Technology, School of Chemistry and Biochemistry

Area of Research—Development of a new pulsed plasma ion source for counterfeit drug analyses by portable ion-mobility spectrometry and rapid liquid chromatography-mass spectrometry (LC-MS).

• Haichen Nie, M.S., Purdue University, College of Pharmacy, Department of Industrial and Physical Pharmacy

Area of Research—Sustainable medicines for Africa—Development of monographs and associated knowledge to increase access to HIV/AIDS medicines for resistant infections (Darunavir-Ritonavir).

• Sharla M. Peters, Postdoctoral candidate, Howard University, College of Medicine, Department of Biochemistry and Molecular Biology

Area of Research—Development of a multiplex real-time polymerase chain reaction assay for the detection of ruminant material in adulterated products.

Each of the Global Fellows will communicate regularly with a scientific liaison from USP headquarters in Rockville, Maryland, providing updates on his or her work and the relevance of its progress to USP’s priorities. In addition, each fellow will be invited to give a poster presentation at an USP-sponsored meeting or event during the course of the academic year.

Source: USP

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here